Cited by 887Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic DiseasesCytokine Signaling Pathways and Interactions

Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity

Open access
El-Haschimi, Karim, Pierroz, Dominique D., Hileman, Stanley M., Bjørbæk, Christian, Flier, Jeffrey S.·2000·Journal of Clinical Investigation

Abstract

Obesity in humans and in rodents is usually associated with high circulating leptin levels and leptin resistance. To examine the molecular basis for leptin resistance, we determined the ability of leptin to induce hypothalamic STAT3 (signal transducer and activator of transcription) signaling in C57BL/6J mice fed either low-fat or high-fat diets. In mice fed the low-fat diet, leptin activated STAT3 signaling when administered via the intraperitoneal (ip) or the intracerebroventricular (icv) route, with the half-maximal dose being 30-fold less when given by the icv route. The high-fat diet increased body-weight gain and plasma leptin levels. After 4 weeks on the diet, hypothalamic STAT3 signaling after ip leptin administration was equivalent in both diet groups. In contrast, peripherally administered leptin was completely unable to activate hypothalamic STAT3 signaling, as measured by gel shift assay after 15 weeks of high-fat diet. Despite the absence of detectable signaling after peripheral leptin at 15 weeks, the mice fed the high-fat diet retained the capacity to respond to icv leptin, although the magnitude of STAT3 activation was substantially reduced. These results suggest that leptin resistance induced by a high-fat diet evolves during the course of the diet and has at least two independent causes: an apparent defect in access to sites of action in the hypothalamus that markedly limits the ability of peripheral leptin to activate hypothalamic STAT signaling, and an intracellular signaling defect in leptin-responsive hypothalamic neurons that lies upstream of STAT3 activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci9842

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Obesity in humans and in rodents placed on a high-fat diet is characterized by hyperleptinemia, and the ability of leptin to suppress food intake and reduce body weight is attenuated.

    “Obesity in both humans and in rodents placed on a HF diet are characterized by hyperleptinemia, and the ability of leptin to suppress food intake and reduce body weight is attenuated (49, 81).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
El-Haschimi, K., Pierroz, D. D., Hileman, S. M., Bjørbæk, C., & Flier, J. S.
Affiliations
Beth Israel Deaconess Medical Center (US)
Corresponding author
Flier, Jeffrey S.
Venue
Journal of Clinical Investigation
Published
2000-06-15
Volume
105
Issue
12
Pages
1827-1832
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2088666203
Cited by
887
References
29
Citations by year
2026: 8 · 2025: 20 · 2024: 13 · 2023: 14 · 2022: 17 · 2021: 37 · 2020: 29 · 2019: 29 · 2018: 35 · 2017: 39 · 2016: 28 · 2015: 42 · 2014: 43 · 2013: 45 · 2012: 45
FWCI
12.97
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Joslin Diabetes Center
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
leptin resistance, hypothalamus, STAT3 signaling, diet-induced obesity, high-fat diet, C57BL/6J mice
MeSH terms
Animals, Cerebral Ventricles, Dietary Fats, DNA-Binding Proteins, Drug Resistance, Humans, Hypothalamus, Injections, Intraventricular, Male, Mice, Inbred C57BL, Obesity, Trans-Activators, Diet, Fat-Restricted, Leptin, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review